What is Kawasaki Syndrome?
What causes Kawasaki Syndrome?
Who gets Kawasaki Syndrome?
How does Kawasaki Syndrome cause disease?
What are the common findings?
How is Kawasaki Syndrome diagnosed?
How is Kawasaki Syndrome treated?
What are the complications?
How can Kawasaki Syndrome be prevented?
What research is being done?
Links to additional information
Marsha Anderson, M.D.
Assistant Professor of Pediatrics
Pediatric Infectious Disease Specialist
Children's Hospital and University of Colorado Health Sciences Center
Mary P. Glode, M.D.
Professor of Pediatrics
Vice-Chair, Department of Pediatrics
Children's Hospital and University of Colorado Health Sciences Center
Kawasaki Syndrome is an illness that occurs in young children between the ages of
6 months and 12 years, with the average age being from 1 to 2 years. The illness
was originally described in Japan in 1967 by a pediatrician named Dr. Tomsaku Kawasaki.
He called the illness "Mucocutaneous Lymph Node Syndrome" because the disease involved
the skin, the mucus membranes (i.e., lips, tongue, mouth, and eyes), and often the
swollen lymph nodes in the neck.
The illness was first described in the United States in the early 1970s, and several
thousand cases are reported each year to the Center for Disease Control (CDC). The
disease involves inflammation of the eyes, the lips, the throat, and the skin. It
also causes inflammation of the blood vessels within the body. The inflammation
of the blood vessels can particularly affect the coronary arteries, resulting in
weakening of the artery wall and formation of coronary artery aneurysms.
The cause of Kawasaki Syndrome remains unknown despite research to identify the
cause. The illness appears to be an inflammatory/infectious disease since it involves
a high fever and a rash, and it occurs suddenly in otherwise healthy children. Blood
tests show a high white blood cell count, and other laboratory tests that measure
inflammation also are elevated, suggesting either a bacterial infection or a bacterial
toxin. Some experts feel that a virus or other infectious agent may cause the disease.
This disease occurs in otherwise healthy children and most often strikes children
between the ages of one and two years. It can occur in children of any ethnicity;
however, there is a higher incidence of this disease in children of Asian ancestry,
whether or not they live in the United States or in Asia. Hispanic children and
African-American children have a higher incidence of this disease than Caucasian
children. The reason for these differences is not known at the present time.
Currently, it is believed that the symptoms of this disease are caused primarily
by the body's inflammatory response to the unknown agent that causes Kawasaki Syndrome.
The damage to the coronary arteries that may occur could be the result of some direct
action by the microorganism or the toxin, or it may be due to the body's immune
response to whatever causes Kawasaki Syndrome.
Usually, the illness begins abruptly, with the onset of a high fever. In untreated
cases, the average duration of the fever is 10 days, much longer than is usually
seen in a viral infection. Within a day or two of the fever, the child develops
red, "bloodshot" eyes and red, cracked lips. A parent may notice a swollen lymph
node in the neck.
The child also develops a blotchy, flat rash over the body. The rash may be very
red and intense in the diaper area. The palms and the soles become bright red, and
the hands and the feet may be swollen. Often, the child is very irritable and difficult
to console. Vomiting and diarrhea also can occur; however, they are less common
than the fever, the rash, the red eyes, the red lips, and irritability. Fourteen
to 21 days after the start of the illness, parents may notice peeling of the hands
and the feet.
Since the cause of Kawasaki Syndrome is not known, there is no blood test that proves
that the patient has Kawasaki Syndrome. It is a clinical diagnosis, and the doctor
must try to prove that the patient does not have any other condition that would
require other therapy. There are many other causes of a rash and a fever in children;
therefore, the diagnosis of Kawasaki Syndrome can be very difficult. Viral infections
(including measles) can mimic this disease, as can reactions to antibiotics and
An allergic reaction to a medication can produce both a fever and a rash. Certain
bacterial infections, such as scarlet fever and toxic shock syndrome, also can mimic
Kawasaki Syndrome. The diagnosis of Kawasaki Syndrome should be considered when
the clinical findings are present, the blood tests suggest significant inflammation,
and no other cause of the findings can be found. A pediatric infectious disease
specialist and a pediatric cardiologist should evaluate children who are suspected
of having Kawasaki Syndrome.
Although the cause of this disease is not known, an effective treatment is available.
IVIG (intravenous gamma globulin) reduces the signs of inflammation in the body
and reduces the risk of development of coronary artery aneurysms. Before IVIG was
used for this disease, the risk of development of coronary artery aneurysms was
If IVIG is given within the first 10 days of the onset of Kawasaki Syndrome, this
risk has now been reduced to between 2% and 4%. High dose aspirin also is used initially
to reduce inflammation. Low dose aspirin is used in the later stages of the disease
to prevent any clots from developing in inflamed blood vessels.
In most children who are treated with IVIG, there are no complications. The fever
and the rash disappear, and the child returns to normal within one to two weeks.
Peeling of the fingers and the toes occurs in children whether or not they are treated
with IVIG. If a child develops coronary artery aneurysms, he/she will need to be
followed by a pediatric cardiologist, and may require long-term aspirin therapy
or other cardiac medications.
Since this is a relatively new disease, long-term follow-up on children (from 30
to 50 years) is not yet available. The short-term follow-up suggests that children
who recover from Kawasaki Syndrome and who have no cardiac abnormalities remain
healthy, active children.
Kawasaki Syndrome cannot be prevented. If a cause of the disease is identified,
it may be possible to develop a vaccine.
Research on Kawasaki Syndrome is being conducted in the United States, in Japan,
and in many other countries around the world. Kawasaki Syndrome has been reported
from all continents. Hundreds of thousands of cases have occurred in children in
Japan. Research focuses on the possible cause of Kawasaki Syndrome, and on new therapies
for children who do not respond to IVIG.
There are numerous Web sites that can be found by searching under "Mucocutaneous
Lymph Node Syndrome" and under "Kawasaki Syndrome" or "Kawasaki Disease."
Bradley, DJ, Glode, MP. Kawasaki disease: the mystery continues. West J Med 1998;168:23-9.
Taubert, KA, Shulman, ST. Kawasaki disease. American Family Physician 1999;59,11:3093-3102.
About the Author
Dr. Anderson is an Assistant Professor of Pediatrics and Pediatric Infectious Disease
Specialist at the Children's Hospital and University of Colorado Health Sciences
Center in Denver, Colorado.
Dr. Glode is an international expert on Kawasaki Disease. She is a Professor of
Pediatrics and Vice-Chair of the Department of Pediatrics at the Children's Hospital
and University of Colorado Health Sciences Center in Denver.
Copyright 2012 Marsha Anderson, M.D., All Rights Reserved
The information contained in these topics is not intended nor implied to be a substitute for professional medical advice, it is provided for educational purposes only. You assume full responsibility for how you choose to use this information.
Always seek the advice of your physician or other qualified healthcare provider before starting any new treatment or discontinuing an existing treatment. Talk with your healthcare provider about any questions you may have regarding a medical condition. Nothing contained in these topics is intended to be used for medical diagnosis or treatment.
By using this website, you accept the information provided herein "AS IS." Neither RemedyConnect nor the providers of the information contained herein will have any liability to you arising out of your use of the information contained herein or make any express or implied warranty regarding the accuracy, content, completeness, reliability, or efficacy of the information contained within this website.
RemedyConnect, Inc. has created this privacy statement in order to demonstrate our firm commitment to your privacy. The following discloses our information gathering and dissemination practices for this website: http://www.remedyconnect.com.
We do not acquire any more information about website visitors than is required by law or is otherwise necessary to provide a high level of service efficiently and securely. Our site's registration form requires users to give us contact information (e.g., their name and e-mail address) and demographic information (e.g., children's birth months, but not birth dates). We use customer contact information from the registration form to (1) send the user pertinent medical and parenting information and (2) allow your local health provider lists of who is registering on that provider's site as a parent/guardian, staff member, doctor, or visitor. Users may opt-out of receiving future mailings; see the choice/opt-out section below.
We use your IP address to help diagnose problems with our server and to administer our Website. Your IP address is used to help identify you and to gather broad demographic information.
Demographic and profile data is also collected at our site. We may use this data to tailor the visitor's experience at our site, showing them content that we think they might be interested in, and displaying the content according to their preferences.
Our site may use order forms to allow users to request information, products, and services.
We will respect your doctor's right to privacy. A doctor typically does not give his/her e-mail address to the parents/guardians of patients. We will not provide the e-mail addresses of doctor(s) in the local practice to users of their site without the doctor(s)' permission. Their site is restricted to use by whomever they wish, and they may deny access to their site to one or more prior users. In unusual cases, doctors may change their private site's access code and arrange for us to e-mail the new access code to approved users.
This site contains links to other sites. RemedyConnect.com is not responsible for the privacy practices or the content of such Websites. See Disclaimers.
We will provide individually-identifiable information about website users to third parties only if we are compelled to do so by order of a duly-empowered governmental authority, we have the express permission of the visitor, or it is necessary to process transactions and provide you services from our affiliates: Live Agent Answering Service, Digital Answering Service, Medical Answering Service and Pediatric Answering Service.
This site may make chat rooms, forums, message boards, and/or news groups available to its users. Please remember that any information that is disclosed in these areas becomes public information and you should exercise caution when deciding to disclose your personal information.
This site has security measures in place to protect the loss, misuse and alteration of the information under our control. For further information regarding our security, please contact us at firstname.lastname@example.org. If you have any concerns regarding the security of information, please do not provide any information to RemedyConnect, Inc. until you are comfortable with our security measures.
You may correct or update your User Registration information at any time, by visiting the User Registration section and providing your personal password that you set at registration. If need be, please email us at email@example.com.
Our site provides users the opportunity to opt-out of receiving e-mail communications from our partners or us, except communications approved by your doctor's practice office. To so opt-out, please email us at firstname.lastname@example.org. To be removed as a user, please email us at the same address. If need be, you may mail requests to us at RemedyConnect, Inc., 9200 E. Mineral Avenue, Suite 100, Centennial, CO 80112. Our telephone number is 303-793-0703.
If you have any questions about this privacy statement, the practices of this site, or your dealings with this Website, you can contact us by email at email@example.com or by mail at our address above.